NRXS

NeurAxis, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$5.75

Price (1 Year)

$8.2 $2.65

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.6 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms.

Website

Analysis (Turkish): NRXS Hissesi Caiz mi, Helal mi? NeurAxis, Inc. Katılım Analizi